Evidence mapPaperPMID 39297971Full record

ReviewPflugers Archiv : European journal of physiology2024

Atypical sphingosine-1-phosphate metabolites-biological implications of alkyl chain length.

Melanie Glueck, Alexandra Lucaciu, Julien Subburayalu, Roxane Isabelle Kestner, Waltraud Pfeilschifter, Rajkumar Vutukuri, Josef Pfeilschifter

Abstract readReview
In one paragraph

Review in Pflugers Archiv : European journal of physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Effect of dietary supplementation of yeast cultureFrontiers in veterinary science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Melanie GlueckInstitute of General Pharmacology and Toxicology, Pharmazentrum Frankfurt, Goethe University, Frankfurt am Main, 60596, Frankfurt, Germany.
Alexandra LucaciuInstitute of General Pharmacology and Toxicology, Pharmazentrum Frankfurt, Goethe University, Frankfurt am Main, 60596, Frankfurt, Germany.
Julien SubburayaluDepartment of Internal Medicine, University Hospital Carl Gustav Carus TU Dresden, Fetscherstraße 74, 01307, Dresden, Saxony, Germany.
Roxane Isabelle KestnerInstitute of General Pharmacology and Toxicology, Pharmazentrum Frankfurt, Goethe University, Frankfurt am Main, 60596, Frankfurt, Germany.
Waltraud PfeilschifterInstitute of General Pharmacology and Toxicology, Pharmazentrum Frankfurt, Goethe University, Frankfurt am Main, 60596, Frankfurt, Germany.
Rajkumar VutukuriInstitute of General Pharmacology and Toxicology, Pharmazentrum Frankfurt, Goethe University, Frankfurt am Main, 60596, Frankfurt, Germany. vutukuri@med.uni-frankfurt.de.
Josef PfeilschifterInstitute of General Pharmacology and Toxicology, Pharmazentrum Frankfurt, Goethe University, Frankfurt am Main, 60596, Frankfurt, Germany. pfeilschifter@em.uni-frankfurt.de.

Funding

Deutsche Forschungsgemeinschaft SFB1039
6 · The paper itself

Abstract

Sphingosine-1-phosphate (S1P) is a bioactive lipid signaling molecule with pleiotropic implications by both auto- and paracrine signaling. Signaling occurs by engaging five G protein-coupled receptors (S1P

Indexed as

LysophospholipidsSignal TransductionSphingosineAnimalsHumansLysophospholipidsSphingosinesphingosine 1-phosphateChain lengthsMyristoyl CoAPalmitoyl CoASerine palmitoyl transferaseSphingolipidsSphingosine-1-phosphate (S1P)Stearoyl CoA

Identifiers

PMID39297971
PMCPMC11582160

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.